Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAMSTA switch study of telmisartan/amlodipine in uncontrolled essential hypertension
2009-017336-40Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of telmisartan and amlodipine in essential hypertension, sponsored by Boehringer Ingelheim. Primary endpoint: Percentage of patients achieving blood pressure control after 12 weeks. Started Mar 2010; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2009-017336-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017336-40.